CAS 1063331-94-1

Formel: C17H16ClN7

InChl: InChI=1S/C17H16ClN7/c1-10-8-11(2)25(23-10)17-21-15(14-16(22-17)24(3)9-19-14)20-13-6-4-12(18)5-7-13/h4-9H,1-3H3,(H,20,21,22)

InChI Key: DVQOPNIPUIOXHU-UHFFFAOYSA-N

SMILES: CC1=CC(=NN1C2=NC(=C3C(=N2)N(C=N3)C)NC4=CC=C(C=C4)Cl)C

N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine

CAS: 1063331-94-1

Formel: C₁₇H₁₆ClN₇

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 353.8088

Ref: IN-DA0096LO

NS13001

CAS: 1063331-94-1

NS13001

Formel: C₁₇H₁₆ClN₇

Reinheit: ≥98%

Molekulargewicht: 353.81

Ref: 54-BUP05712

NS13001

CAS: 1063331-94-1

NS13001, an oral SK channel modulator, shows promise for SCA2 therapy; EC50: 1.8 µM (SK2), 0.14 µM (SK3).

Formel: C₁₇H₁₆ClN₇

Reinheit: 99.55%

Farbe und Form: White Solid

Molekulargewicht: 353.81

Ref: TM-T16345

N-(4-Chlorophenyl)-2-(3,5-Dimethyl-1H-Pyrazol-1-Yl)-9-Methyl-9H-Purin-6-Amine

CAS: 1063331-94-1

N-(4-Chlorophenyl)-2-(3,5-Dimethyl-1H-Pyrazol-1-Yl)-9-Methyl-9H-Purin-6-Amine

Formel: C₁₇H₁₆ClN₇

Reinheit: 95%

Molekulargewicht: 353.81

Ref: 54-OR1025830

NS13001

CAS: 1063331-94-1

N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine

Formel: C₁₇H₁₆ClN₇

Reinheit: 95%

Molekulargewicht: 353.81

Ref: IN-DG303839

N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine

CAS: 1063331-94-1

Formel: C₁₇H₁₆ClN₇

Reinheit: 95%

Molekulargewicht: 353.81

Ref: 10-F498455

N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine

Kontrolliertes Produkt

CAS: 1063331-94-1

Formel: C₁₇H₁₆ClN₇

Farbe und Form: Neat

Molekulargewicht: 353.809

Ref: TR-N110535

NS13001

CAS: 1063331-94-1

NS13001 is a small molecule that has been shown to induce apoptotic cell death in leukemia cells. It binds to the cytochrome p450 protein, which is an important regulator of intracellular calcium. NS13001 binds to calmodulin and alters calcium signaling, leading to the activation of pro-apoptotic genes. This drug also increases the cytosolic calcium concentration by activating the ryanodine receptor, which results in cerebellar Purkinje neurons degeneration. NS13001 has been shown to be effective against lymphocytic leukemia cells that express activated caspase 3 and microglia cells.

Formel: C₁₇H₁₆ClN₇

Reinheit: Min. 95%

Molekulargewicht: 353.81 g/mol

Ref: 3D-NSB33194